Stay updated on Carfilzomib, Iberdomide, Dexamethasone Clinical Trial

Sign up to get notified when there's something new on the Carfilzomib, Iberdomide, Dexamethasone Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Carfilzomib, Iberdomide, Dexamethasone Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    Added government-operating-status notice and a MedlinePlus Genetics topic on multiple myeloma; updated bibliographic entry with an erratum note and corrected author name, and updated revision tag from v3.1.0 to v3.2.0. If this conflicts with deleted content, the new, corrected status and references prevail.
    Difference
    1%
    Check dated 2025-10-06T16:05:17.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    Update adds primary contact details and a crucial literature reference about Cereblon as a target, while removing a related MedlinePlus Genetics topic and an erratum notice; overall content enrichment with minor corrections.
    Difference
    0.2%
    Check dated 2025-09-29T09:59:42.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    Added a new MedlinePlus Genetics topic: Multiple myeloma, expanding core content with genetics-related information.
    Difference
    0.1%
    Check dated 2025-09-22T05:34:46.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    Updated the citation with an erratum and corrected author name; bumped the page revision from v3.0.1 to v3.0.2.
    Difference
    0.2%
    Check dated 2025-09-15T00:22:51.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content, pricing, or availability.
    Difference
    0.1%
    Check dated 2025-09-07T20:48:19.000Z thumbnail image
  7. Check
    48 days ago
    Change Detected
    Summary
    The web page has been updated to include a new facility name and location details, specifically mentioning Washington D.C., along with new medical terms related to plasma cell myeloma and specific drugs like carfilzomib and iberdomide. Several previous terms and topics related to multiple myeloma and various drug categories have been removed.
    Difference
    1%
    Check dated 2025-08-31T12:56:36.000Z thumbnail image

Stay in the know with updates to Carfilzomib, Iberdomide, Dexamethasone Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Carfilzomib, Iberdomide, Dexamethasone Clinical Trial page.